食管癌贲门癌患者血清 C-反应蛋白监测的临床价值

Clinical Assessment of Serum C—reactive Prctem in Patients with Esophageal and Gastric Cardiac Carcinoma

采用Ｃ—反应蛋白免疫单相扩散板对６１例食管癌、贲门癌患者术前，术后１日，４日和８日的血清Ｃ—反应蛋白含量进行测定。２３％患者Ｃ—反应蛋白增高；术后第１日Ｃ—反应蛋白平均增加８．７８倍；术后第４日和第８日，无并发症的患者Ｃ—反应蛋白分别回降７２．７％和８７．８％，而有并发症的患者分别回降２８．６％和６８．１％。本文结果提示，Ｃ—反应蛋白测定可反映开胸术后组织损伤、修复过程、可预测术后并发症，对手术指证的选择有指导意义。

Serum C-reactive protein (CRP) was measured in 61 patients with Carcinoma of esophagus and gastric cardia before and pestoperative time.CRP was increased in 14(23%) Patients preoperative periods.The amount of CRP on first day during psstoperation increased by 8.87 times over preoperation.It has decreasecl to 72.7% in patients without complication on fouth day and to 87.8% on eighth day aftor operation. But it has only lowored 28.6% and 68.1% separatly in patients with complication in the Some time.It suggests that Complications might occur in patients with higher CRP follewing operation CRP test has reveraled the course of injury and repairation of tissue.CRP examination during preoperation can direct the choile of indication.